Cardiovascular Disease News and Research RSS Feed - Cardiovascular Disease News and Research

According to the Centers for Disease Control and Prevention, about 700,000 people die annually of cardiovascular disease. Cardiovascular disease involves the heart and vessels and is the number one killer in the U.S. accounting for nearly 30-percent of all deaths. Cardiovascular disease has a number of forms but the most common are myocardial infarction and angina pectoris which affect the heart itself. There are well known environmental risk factors associated with cardiovascular disease such as smoking, diet, inactivity and increased alcohol use. Heredity also plays a factor in cardiovascular disease since other risk factors like high blood pressure and high LDL cholesterol tend to run in families. Cardiovascular disease can be reduced by controlling environmental factors and understanding the genetic factors that put people at greater risk for heart disease.
Novel document on ventricular arrhythmias published in EP Europace

Novel document on ventricular arrhythmias published in EP Europace

The first expert consensus on ventricular arrhythmias is published today. The novel document compiles current evidence on the diagnosis and management of ventricular arrhythmias and was agreed by international experts from three continents. [More]
Initiatives to reduce deaths from heart failure for patients worldwide

Initiatives to reduce deaths from heart failure for patients worldwide

The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) is calling for global policy change relating to heart failure. An international white paper, Heart failure: preventing disease and death worldwide, was published in May 2014. [More]
Recommendations on arrhythmia management in ACS patients published in EP Europace

Recommendations on arrhythmia management in ACS patients published in EP Europace

The first multidisciplinary recommendations on the management of arrhythmias in patients with acute coronary syndromes (ACS) are published today in EP Europace. [More]
ACCA Clinical Decision-Making Toolkit mobile app helps make quick and correct decision

ACCA Clinical Decision-Making Toolkit mobile app helps make quick and correct decision

The ACCA Clinical Decision-Making Toolkit mobile app is now available on the App Store and Google Play. When dealing with acute cardiovascular diseases, a few seconds can make the difference and instant access to the best recommendations can save lives. [More]
Bariatric surgery can provide valuable benefits to the brain

Bariatric surgery can provide valuable benefits to the brain

At bariatric facilities like Dr. Feiz and Associates, the life-changing benefits of bariatric surgery, including reduced risk of diabetes, cardiovascular disease and endocrine disorders are well established. [More]
New journal on cardiovascular pharmacotherapy from ESC

New journal on cardiovascular pharmacotherapy from ESC

A new ESC journal on cardiovascular pharmacotherapy is launched today at ESC Congress by the ESC and Oxford University Press. [More]
Solid-head power toothbrushes retain less bacteria than hollow-head toothbrushes

Solid-head power toothbrushes retain less bacteria than hollow-head toothbrushes

Solid-head power toothbrushes retain less bacteria compared to hollow-head toothbrushes, according to researchers at The University of Texas Health Science Center at Houston School of Dentistry. [More]
Specific foods and dietary patterns help prevent, control diabetes

Specific foods and dietary patterns help prevent, control diabetes

In a comprehensive review of recent randomized clinical trials and observational studies of diabetes and nutrition, Joslin Diabetes Center and Harvard School of Public Health investigators have identified specific foods and dietary patterns that are beneficial in preventing and controlling diabetes. [More]
Amgen seeks FDA approval for evolocumab to treat patients with high cholesterol

Amgen seeks FDA approval for evolocumab to treat patients with high cholesterol

Amgen today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration for evolocumab seeking approval for the treatment of high cholesterol. [More]
Risk-based treatment approach should be considered for patients with hypertension

Risk-based treatment approach should be considered for patients with hypertension

Blood pressure-lowering treatment should target patients at greatest cardiovascular risk and not just those with the highest baseline levels, suggest findings of a meta-analysis. [More]
Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 3 study evaluating ISIS-APOCIIIRx in patients with familial chylomicronemia syndrome (FCS). FCS is a rare orphan disease, characterized by extremely high triglyceride levels, that affects an estimated 3,000 to 5,000 patients worldwide. [More]
Amgen's ivabradine receives FDA priority review designation for treatment of chronic heart failure

Amgen's ivabradine receives FDA priority review designation for treatment of chronic heart failure

Amgen today announced the U.S. Food and Drug Administration has granted priority review designation for ivabradine for the treatment of chronic heart failure (HF). [More]
People from low socio-economic positions in Britain still eat more salt

People from low socio-economic positions in Britain still eat more salt

People from low socio-economic positions in Britain still eat more salt than those from higher socio-economic positions, irrespective of where they live. [More]
New guidelines can improve the way statin drugs prescribed to patients at cardiovascular risk

New guidelines can improve the way statin drugs prescribed to patients at cardiovascular risk

New national guidelines can improve the way statin drugs are prescribed to patients at risk for cardiovascular disease, a Yale University study has found. [More]
Authors emphasize benefits of calcium and vitamin D supplements on bone health

Authors emphasize benefits of calcium and vitamin D supplements on bone health

Calcium and vitamin D are essential to keeping bones strong, dense and healthy as we age, as well as preventing bone loss, osteporosis, and skeletal fractures. [More]
Female rats whose great grandparents exposed to toxins become more vulnerable to stress

Female rats whose great grandparents exposed to toxins become more vulnerable to stress

Scientists have known that toxic effects of substances known as endocrine disrupting chemicals (EDCs), found in both natural and human-made materials, can pass from one generation to the next, but new research shows that females with ancestral exposure to EDC may show especially adverse reactions to stress. [More]
Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

Acromegaly is a chronic, life-threatening disease triggered by a benign tumour of the pituitary gland causing excessive growth hormone release. Oversupply of growth hormone stimulates liver, fat and kidney cells to produce excess levels of Insulin-Like Growth Factor I (IGFI), which causes abnormal growth of the bones of the hands, face and feet and bodily organs. [More]
Black carbon may increase risk of cardiovascular disease in women

Black carbon may increase risk of cardiovascular disease in women

Black carbon pollutants from wood smoke are known to trap heat near the earth's surface and warm the climate. A new study led by McGill Professor Jill Baumgartner suggests that black carbon may also increase women's risk of cardiovascular disease. [More]
Study sheds light on direct causal relationship between smoking and mortality

Study sheds light on direct causal relationship between smoking and mortality

It is a fact that smoking is harmful and associated with deadly diseases such as cancer and cardiovascular disease. [More]
American Heart Association issues new policy recommendations on use of e-cigarettes

American Heart Association issues new policy recommendations on use of e-cigarettes

The American Heart Association issued new policy recommendations today on the use of e-cigarettes and their impact on tobacco-control efforts. The guidance was published in the association's journal, Circulation. [More]